Research on Viral Replication Mechanisms and Pathogenesis
Research on Antiviral Drug Resistance and Viral Evolution
Vaccine Development Based on Virus Vector Technology
Education
Ph.D. in Biological Science, KU Leuven, 1993
Career
Co-founder, The Belgian VirusBank Platform 2022 ~ Present
Co-founder of and scientific advisor, AstriVax 2022 ~ Present
Full Professor of Virology, Faculty of Medicine, KU Leuven 2008 ~ Present
Achievements
Career Experience - 27 years of experience in antiviral drug and vaccine development research
Publications - Published 681 papers in prestigious international journals such as Nature, Nat. Med., Nat. Commun., Science, Lancet, Lancet Gastroenterol. Hepatol., and Lancet Infect. Dis.
Patents - 66 patents related to viral treatments and prevents, with 4 technologies transferred, including antiviral agents (Rhinovirus–Novartis/Gilead, HCV–Gilead, RSV–Gilead, DENV–Janssen)